Advanced in Parkinson's Disease

Lene Wermuth

Odense, DK 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Parkinson's Disease
Odense, DK 
OverviewLocationsClinical Research

Overview

Lene Wermuth practices in Odense, Denmark. Ms. Wermuth is rated as an Advanced expert by MediFind in the treatment of Parkinson's Disease. Her top areas of expertise are Dementia, Alzheimer's Disease, Movement Disorders, and Parkinson's Disease.

Her clinical research consists of co-authoring 38 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 21 articles in the study of Parkinson's Disease.

Gender
Female

Locations

Odense, Denmark
Other Locations
Slagelse, 4200, Denmark
Odense C, 5000, Denmark
Denmark

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enrollment Status: Recruiting
Publish Date: February 28, 2024
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients With Huntington's Disease
Enrollment Status: Terminated
Publish Date: April 25, 2022
Intervention Type: Drug
Study Drug: WVE-120102
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease
A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120101 Administered Intrathecally in Patients With Huntington's Disease
Enrollment Status: Terminated
Publish Date: February 10, 2022
Intervention Type: Drug
Study Drug: WVE-120101
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trial

38 Total Publications

Hearing Loss, Hearing Aid Use, and Risk of Dementia in Older Adults.
Hearing Loss, Hearing Aid Use, and Risk of Dementia in Older Adults.
Journal: JAMA otolaryngology-- head & neck surgery
Published: January 04, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Wermuth's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile